Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Pemetrexed Plus Cisplatin Neoadjuvant Therapy Followed By Surgery and Radiation in Mesothelioma
| Conditions: | Mesothelioma |
| Start Date: | June 1, 2005 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT00192010 |
| Study Type: | Interventional |
| Intervention: | Drug: pemetrexed|Drug: cisplatin |
| Study Design: | Allocation: Non-Randomized|Control: Uncontrolled|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Eli Lilly and Company |
| Ages: | Adult|Senior |
| Enrollment: | 54 |
| Funded By: | Industry |
| First Received: | September 12, 2005 |
| End Date: | February 1, 2010 |
| Last Updated: | August 5, 2010 |
| Last Verified: | August 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
